Brennan John Joseph 4
4 · AMERICAN EXPRESS CO · Filed May 7, 2026
Research Summary
AI-generated summary of this filing
American Express (AXP) Director John Brennan Receives 742 Share Units
What Happened
- John Brennan, a director of American Express Company (AXP), was granted 742.115 share-equivalent units on 2026-05-05. The Form 4 reports the award as a derivative acquisition with an acquisition price of $0.00 (i.e., a compensation grant rather than an open-market purchase).
Key Details
- Transaction date: 2026-05-05; filing date: 2026-05-07 (file appears timely).
- Amount: 742.115 Share Equivalent Units (SEUs); reported acquisition price $0.00.
- Shares owned after transaction: not specified in the supplied filing details.
- Footnotes: F1 — each SEU equals the value of one common share; F2 — units were acquired under the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a director; F3 — units are convertible immediately upon termination and have no expiration date.
- Transaction type: Award/Grant (derivative equity award), code A on the Form 4.
Context
- These SEUs are a deferred compensation award for board service and are payable in cash when the director leaves the board; they do not represent immediate stock ownership or an open-market purchase. Such grants are typically routine compensation and should be interpreted accordingly rather than as a direct trading signal.
Insider Transaction Report
Form 4
Brennan John Joseph
Director
Transactions
- Award
Share Equivalent Units
[F1][F2][F3]2026-05-05+742.115→ 29,205.217 total→ Common Stock (742.115 underlying)
Footnotes (3)
- [F1]Each Share Equivalent Unit reflects the value of one common share.
- [F2]The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director.
- [F3]The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date.
Signature
/s/ James J. Killerlane III, attorney-in-fact|2026-05-07